Skip to main content

Table 2 Association between Elevated Antiphospholipid Antibody Titers (Present vs. Absent) and Four Adverse Outcomes in 141,286 Women Delivering in Florida in 2001

From: Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset

 

Unadjusted

Adjusted

Outcome

Odds Ratio

[95% CI*]

P-value

Odds Ratio

[95% CIa*]

P-value

Preeclampsia or Eclampsia

2.77

[1.44, 5.35]

0.002

2.93†

[1.51, 5.69]

0.0015

Systemic lupus erythematosus

67.45

[26.90, 169.12]

< 0.0001

61.24‡

[24.29, 154.44]

< 0.0001

Placental insufficiency

4.33

[1.89, 9.93]

0.0005

4.58§

[2.00, 10.51]

0.0003

Prolonged length of stay ¶

4.10

[2.67, 6.30]

< 0.0001

3.93∥

[2.55, 6.06]

< 0.0001

  1. * CI: Confidence interval
  2. † Adjusted for race, age, Medicaid status, diabetes, obesity, and primigravida status
  3. ‡ Adjusted for race and age
  4. § Adjusted for race, age, and Medicaid status
  5. ∥ Adjusted for race, age, Medicaid status, and diabetes
  6. ¶ Defined as a length of stay of > 3 days